Cytek BioSciences Inc
Research Cytek BioSciences Inc (CTKB) on Bullrun: market cap USD 595.32M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCTKB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 595.32M
- Financial periodQ2 2026
- RevenueUSD 48.14M
- Net income-USD 12.16M
- Free cash flow-USD 877.00K
- Gross margin58.9%
Valuation Snapshot
latest market cap is USD 595.32M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 201.49M | -USD 66.54M | -USD 8.77M | 51.8% | -0.51 | USD 90.85M | USD 23.74M | USD 341.74M |
| FY2024 | USD 200.45M | -USD 6.02M | USD 21.85M | 55.4% | -0.17 | USD 98.72M | USD 17.02M | USD 395.74M |
| FY2023 | USD 193.02M | -USD 12.15M | USD 633.00K | 56.7% | -0.09 | USD 167.30M | USD 14.14M | USD 393.06M |
| FY2022 | USD 164.04M | USD 2.48M | -USD 21.98M | 61.6% | 0.02 | USD 296.60M | USD 14.85M | USD 425.55M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 595.32M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 649.18M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 838.55M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.24B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.38B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 2.18B | n/a | n/a | n/a |
About Cytek BioSciences Inc
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cytek BioSciences Inc's market cap?
Cytek BioSciences Inc's market capitalization is USD 595.32M.
What does Cytek BioSciences Inc do?
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications.